WHO ICTRP trial
To study efficacy, safety and tolerability of intra-artecular regimens of LNA043…
CTRI/2021/10/037098 · Clinical Trials Registry India (CTRI) · Recruiting
Key facts
| Trial ID | CTRI/2021/10/037098 |
|---|---|
| Public title | To study efficacy, safety and tolerability of intra-artecular regimens of LNA043 versus placebo in adult patients with symptomatic knee osteoarthritis |
| Scientific title | A 5-year, randomized, double blind, placebo-controlled, multi-center study assessing the efficacy, safety, and tolerability of intra-articular regimens of LNA043 versus placebo in patients with symptomatic knee osteoarthritis (ONWARDS) - ONWARDS |
| Primary sponsor | Novartis Healthcare Pvt Ltd |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Recruiting |
| Study type | Interventional |
| Phase | Phase 2 |
| Countries | Argentina;Australia;Austria;Canada;China;Czech Republic;Denmark;Estonia;Germany;Hungary;India;Japan;Lithuania;Mexico;Poland;Spain;Taiwan;United Kingdom;United States of America |
| Conditions | Health Condition 1: M179- Osteoarthritis of knee, unspecified |
| Interventions | Intervention1: LNA043: LNA043 in different doses (20 mg and 40 mg), number of injections in a cycle (1 vs 3) and dosing cycle frequency (every 6 months vs every 12 months) Control Intervention1: Placebo: Saline solution |
| Registration date | May 10, 2021 |
| Target size | 550 |
| Secondary IDs | 2020-004897-22;CLNA043A12202 Version 0.0 dated 23 Feb 2021;NCT04864392 |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: